Bio-Techne Corporation
TECH · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $8,104,455 | $11,293,470 | $12,830,522 | $13,594,874 |
| - Cash | $162,186 | $151,791 | $180,571 | $172,567 |
| + Debt | $444,058 | $419,538 | $454,965 | $325,971 |
| Enterprise Value | $8,386,327 | $11,561,217 | $13,104,916 | $13,748,278 |
| Revenue | $1,219,635 | $1,159,060 | $1,136,702 | $1,105,599 |
| % Growth | 5.2% | 2% | 2.8% | – |
| Gross Profit | $790,272 | $769,725 | $769,815 | $756,496 |
| % Margin | 64.8% | 66.4% | 67.7% | 68.4% |
| EBITDA | $216,875 | $313,136 | $457,112 | $413,764 |
| % Margin | 17.8% | 27% | 40.2% | 37.4% |
| Net Income | $73,400 | $168,105 | $285,263 | $272,051 |
| % Margin | 6% | 14.5% | 25.1% | 24.6% |
| EPS Diluted | 0.46 | 1.05 | 1.76 | 1.66 |
| % Growth | -56.2% | -40.3% | 6% | – |
| Operating Cash Flow | $287,556 | $298,981 | $254,393 | $325,272 |
| Capital Expenditures | -$31,006 | -$62,877 | -$38,244 | -$44,908 |
| Free Cash Flow | $256,550 | $236,104 | $216,149 | $280,364 |